SATIV Trademark

Trademark Overview


On Thursday, October 3, 2019, a trademark application was filed for SATIV with the United States Patent and Trademark Office. The USPTO has given the SATIV trademark a serial number of 79276064. The federal status of this trademark filing is ABANDONED - AFTER EX PARTE APPEAL as of Tuesday, January 17, 2023. This trademark is owned by GW Pharma Limited. The SATIV trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and veterinary preparations, namely, for use in treating pain, neuropathic pain, cancer pain, multiple sclerosis, spinal cord injury, bladder dysfunction, peripheral neuropathy, spasticity, cancer and cancer symptoms, perioperative pain, rheumatoid arthritis, inflammatory bowel disease, ulcerative colitis, hypoxic-ischaemic encephalopathy, symptoms of neurogenic disorders, movement disorders, essential tremors, psychotic disorders, diseases of the central nervous system, stroke and head injuries, motion sickness and chemically induced sickness, spasticity, psychiatric illnesses, post-traumatic stress disorder, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with Type II Diabetes, bulimia, schizophrenia, Crohn's disease, Alzheimer's disease, bone disorders, inflammatory disorders, sleep and sleep disorders, and drug, alcohol, and nicotine abuse; herbs for medicinal purposes; medicinal herbs; medicinal oils; medicinal infusions, each of the for...
sativ

General Information


Serial Number79276064
Word MarkSATIV
Filing DateThursday, October 3, 2019
Status603 - ABANDONED - AFTER EX PARTE APPEAL
Status DateTuesday, January 17, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical and veterinary preparations, namely, for use in treating pain, neuropathic pain, cancer pain, multiple sclerosis, spinal cord injury, bladder dysfunction, peripheral neuropathy, spasticity, cancer and cancer symptoms, perioperative pain, rheumatoid arthritis, inflammatory bowel disease, ulcerative colitis, hypoxic-ischaemic encephalopathy, symptoms of neurogenic disorders, movement disorders, essential tremors, psychotic disorders, diseases of the central nervous system, stroke and head injuries, motion sickness and chemically induced sickness, spasticity, psychiatric illnesses, post-traumatic stress disorder, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with Type II Diabetes, bulimia, schizophrenia, Crohn's disease, Alzheimer's disease, bone disorders, inflammatory disorders, sleep and sleep disorders, and drug, alcohol, and nicotine abuse; herbs for medicinal purposes; medicinal herbs; medicinal oils; medicinal infusions, each of the foregoing for use in treating pain, neuropathic pain, cancer pain, multiple sclerosis, spinal cord injury, bladder dysfunction, peripheral neuropathy, spasticity, cancer and cancer symptoms, perioperative pain, rheumatoid arthritis, inflammatory bowel disease, ulcerative colitis, hypoxic-ischaemic encephalopathy, symptoms of neurogenic disorders, movement disorders, essential tremors, psychotic disorders, diseases of the central nervous system, stroke and head injuries, motion sickness and chemically induced sickness, spasticity, psychiatric illnesses, post-traumatic stress disorder, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with Type II Diabetes, bulimia, schizophrenia, Crohn's disease, Alzheimer's disease, bone disorders, inflammatory disorders, sleep and sleep disorders, and drug, alcohol, and nicotine abuse; pure extracts of medicinal plants and herbs for pharmaceutical use; foodstuffs for medicinal purposes; herb teas for medicinal purposes

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 10, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGW Pharma Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Tuesday, February 13, 2024FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, January 22, 2024FINAL DISPOSITION NOTICE SENT TO IB
Saturday, January 20, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Monday, January 23, 2023ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL
Friday, January 20, 2023ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL
Tuesday, January 17, 2023ABANDONMENT - AFTER EX PARTE APPEAL
Tuesday, January 17, 2023EXPARTE APPEAL TERMINATED
Monday, December 5, 2022EXPARTE APPEAL DISMISSED - FAILURE TO FILE BRIEF
Wednesday, August 17, 2022NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Wednesday, August 17, 2022SUBSEQUENT FINAL EMAILED
Wednesday, August 17, 2022SUBSEQUENT FINAL REFUSAL WRITTEN
Wednesday, July 6, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 5, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 5, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, January 3, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, January 3, 2022NON-FINAL ACTION E-MAILED
Monday, January 3, 2022NON-FINAL ACTION WRITTEN
Saturday, November 20, 2021NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, November 9, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 9, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 8, 2021ASSIGNED TO LIE
Wednesday, November 3, 2021TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, November 3, 2021EX PARTE APPEAL-INSTITUTED
Wednesday, November 3, 2021JURISDICTION RESTORED TO EXAMINING ATTORNEY
Wednesday, November 3, 2021EXPARTE APPEAL RECEIVED AT TTAB
Wednesday, September 15, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, September 15, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, September 15, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, September 15, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sunday, June 27, 2021NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, June 9, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, June 9, 2021NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Monday, May 3, 2021NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, May 3, 2021FINAL REFUSAL E-MAILED
Monday, May 3, 2021FINAL REFUSAL WRITTEN
Saturday, March 27, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 26, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 26, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, October 18, 2020REFUSAL PROCESSED BY IB
Monday, September 28, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, September 28, 2020REFUSAL PROCESSED BY MPU
Saturday, September 5, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, September 4, 2020NON-FINAL ACTION WRITTEN
Monday, August 31, 2020ASSIGNED TO EXAMINER
Thursday, January 16, 2020ASSIGNED TO EXAMINER
Tuesday, January 14, 2020APPLICATION FILING RECEIPT MAILED
Friday, January 10, 2020ASSIGNED TO EXAMINER
Friday, January 10, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 9, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB